NCT06624969 Virtual Reality in Reducing Acute Orthopedic Pain
| NCT ID | NCT06624969 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-04-23 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-04-23 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of this research is to show that a virtual reality (VR) service line is feasible and can sustain itself with the ability to take care of patients. Additionally, the investigators aim to learn about the limitations of a service line and provide a pathway for future improvements in building a VR service line that is optimally aligned with the user's needs. Secondary aims are to evaluate the clinical aspects of the patient's outcomes including length of stay, morphine equivalents in pain medicine required during the hospital stay, and user experiences.
Eligibility Criteria
Inclusion Criteria: 1. Hospitalized with an orthopedic fracture 2. Able to participate fully in all aspects of the study 3. Able to understand and sign informed consent 4. Individuals with unaided vision or those who can correct their vision using contact lenses Exclusion Criteria: 5. Non-English speaking 6. Self-reported history of acute and/or chronic severe motion sickness 7. The presence of a facial/head deformity that will prohibit the wearing of a VR head mounted display. 8. Legally blind or deaf 9. Have had a seizure within the past 1 year 10. Have current (within the past 30 days) clinically significant acute or chronic progressive or unstable/uncontrolled neurologic disorder 11. Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence
Contact & Investigator
Scott Helgeson, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06624969 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06624969 currently recruiting?
Yes, NCT06624969 is actively recruiting participants. Contact the research team at helgeson.scott@mayo.edu for enrollment information.
Where is the NCT06624969 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT06624969 clinical trial?
NCT06624969 is sponsored by Mayo Clinic. The principal investigator is Scott Helgeson, MD at Mayo Clinic. The trial plans to enroll 100 participants.